Vitamins for Anxiety and Depression
Vitamins are not first-line treatments for anxiety and depression—prescription SSRIs and cognitive behavioral therapy are the evidence-based standards of care. However, specific B vitamins and vitamin D may serve as useful adjunctive strategies when nutritional deficiencies exist or as complementary approaches alongside standard treatment.
Primary Treatment Framework
The available clinical guidelines consistently prioritize pharmacotherapy (SSRIs/SNRIs) and cognitive behavioral therapy over vitamin supplementation 1, 2, 3. When treating comorbid anxiety and depression, always address depression first, as this is the primary affective disruptor and anxiety often improves secondarily 2, 4.
Evidence-Based Vitamin Recommendations
B Vitamins (Strongest Evidence)
Vitamin B6 (Pyridoxine)
- Dosing: 100 mg daily for at least 4 weeks 5, 6
- Evidence: High-dose B6 supplementation (100 mg/day for 1 month) significantly reduced self-reported anxiety and enhanced inhibitory GABAergic neural function 6. This represents the most recent high-quality evidence for a specific vitamin intervention.
- Mechanism: Increases GABA synthesis, enhancing inhibitory neurotransmission
- Clinical note: More effective for anxiety than depression specifically
Vitamin B1 (Thiamine) + B2 (Riboflavin) Combination
- Dosing: 100 mg of each daily for 4 weeks 5
- Evidence: A 2025 randomized controlled trial showed significant reduction in stress scores (PSS decreased from 21.5 to 15.5, p<0.05) and improved sleep quality, but no significant effect on anxiety 5
- Best for: Stress reduction and sleep disturbances rather than primary anxiety/depression
Folic Acid (Vitamin B9) + Vitamin B12
- Dosing: Folic acid 800 mcg daily + Vitamin B12 1 mg daily 7
- Evidence: Improves response to antidepressants, particularly in patients with low baseline folate/B12 levels 8, 7
- Mechanism: Essential for S-adenosylmethionine (SAM) formation and one-carbon metabolism crucial for neurotransmitter synthesis
- Clinical pearl: Check baseline folate and B12 levels; supplementation is most effective when correcting deficiency 9
Vitamin D
- Dosing: Variable in studies; typical therapeutic doses range from 1000-4000 IU daily
- Evidence: Adjunctive vitamin D therapy shows modest benefits for depressive symptoms, particularly in deficient patients 8
- Recommendation: Check 25-OH vitamin D levels; supplement if <30 ng/mL
Antioxidant Vitamins (Weaker Evidence)
- Vitamins A (β-carotene), C, and E: A 2012 study showed reduced anxiety/depression scores after 6 weeks of supplementation, but this is older evidence with limited replication 10
- Not recommended as primary intervention given stronger alternatives
Clinical Algorithm
Step 1: Assess and Treat with Evidence-Based First-Line Therapies
- Initiate SSRI/SNRI pharmacotherapy 1, 3
- Refer for cognitive behavioral therapy 1, 2
- If both anxiety and depression present, treat depression first 2, 4
Step 2: Consider Vitamin Supplementation as Adjunct
- For anxiety predominant: Vitamin B6 100 mg daily 6
- For depression with poor antidepressant response: Check folate/B12 levels; supplement with folic acid 800 mcg + B12 1 mg daily if low 7
- For stress and sleep disturbances: B1 100 mg + B2 100 mg daily 5
- If vitamin D deficient: Supplement to achieve levels >30 ng/mL 8
Step 3: Monitor Response
- Reassess at 4 and 8 weeks using standardized scales 2
- If no improvement by 8 weeks, adjust the treatment regimen 2
Important Caveats
Limitations of vitamin therapy:
- Vitamins show modest effect sizes compared to standard pharmacotherapy
- Most beneficial when correcting documented deficiencies 9
- Should never replace evidence-based treatments 1, 2
- The 2023 ASCO guidelines explicitly note that pharmacotherapy is not recommended as first-line for depression in cancer survivors, with CBT preferred—this underscores the primacy of psychological interventions even in medical populations 2
Common pitfall: Patients may delay seeking effective treatment by trying vitamins alone. Always initiate standard care concurrently rather than sequentially trialing vitamins first.
Quality of evidence: While recent studies on B vitamins show promise 5, 6, the overall certainty of evidence for vitamins remains lower than for SSRIs and CBT, which have decades of robust RCT data 1, 3.